A Cole Eye Institute research team will study the role of inflammation in retinal regeneration in zebrafish, with support from a new four-year grant from the National Eye Institute.
Read MoreEye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood
Numerous cancer treatments have been shown to have side effects such as ocular toxicities.
Blurry Vision, Ocular Motility Issues: Cancer Metastasis to the Eye Takes Many Forms
Cancer metastasis to the eye can manifest as ocular motility issues, blurry vision, and sunken or bulging eyes. Ophthalmologists can contribute to prompt diagnosis and treatment to improve a patient’s quality of life.
Don’t Believe Everything Chatbots Say About Ophthalmic Research
A JAMA Ophthalmology study reveals the pitfalls of using artificial intelligence tools like ChatGPT to generate ophthalmic research abstracts and references.
Goniotomy and GATT Aren’t Just for Mild to Moderate Glaucoma
Minimally invasive glaucoma surgery (MIGS) isn’t just for mild to moderate conditions. It is safer and may be more effective than tube shunts in patients with uveitic and steroid-induced glaucoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
5 Practical Uses for OCT-A in AMD and Diabetic Retinopathy
Optical coherence tomography angiography (OCT-A) can be a useful adjunct in retina practices with or without fluorescein angiography. Here are five uses for the imaging technology in managing age-related macular degeneration (AMD) and diabetic retinopathy.
Retinoblastoma: When Eyeshine Indicates Something Serious (Podcast)
Leukocoria (white pupil) is the most common symptom of retinoblastoma, a rare eye cancer that affects only children under age 5.
Case Study: Bilateral DMEK in 1-Year-Old with Posterior Polymorphous Corneal Dystrophy (Video)
A 1-year-old with posterior polymorphous corneal dystrophy is one of the youngest patients ever to have a bilateral cornea transplant via Descemet’s membrane endothelial keratoplasty (DMEK).
How to Use Topical Losartan to Potentially Treat Cornea Damage
Topical losartan potentially can help reverse corneal scarring fibrosis caused by disease, injury and surgical complications. More clinical trials are needed to evaluate its efficacy and safety. The pioneering investigator, Steven E. Wilson, MD, offers guidance.
Exudative Stability Key to Anti-VEGF Outcome in nAMD
Stabilizing the volume of exudative fluid, including subretinal fluid, may help maximize anti-VEGF treatment outcomes for patients with nAMD.
Unlocking Precision Medicine in RVO: When Anti-VEGF Therapy Isn’t Effective
Although anti-VEGF therapy is the current gold-standard treatment for retinal vein occlusion, not all patients respond to it. A study has found that volume of intraretinal fluid, among other factors detectable with optical coherence tomography, may help predict treatment response.